| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029121 |
| Receipt No. | R000033302 |
| Official scientific title of the study | Treatment strategies for acute wounds by cold atmospheric pressure plasma:Prospective study on wound healing after fractional laser irradiation |
| Date of disclosure of the study information | 2017/09/15 |
| Last modified on | 2018/05/29 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Treatment strategies for acute wounds by cold atmospheric pressure plasma:Prospective study on wound healing after fractional laser irradiation | |
| Title of the study (Brief title) | Treatment strategies for acute wounds by cold atmospheric pressure plasma | |
| Region |
|
|
| Condition | ||||
| Condition | Wounds after fractional laser irradiation | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Evaluation of usefulness of cold atmospheric pressure plasma on wound area after fractional laser irradiation. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of pigmentation after 3 months |
| Key secondary outcomes | Evaluation of transpiration of skin
Evaluation of skin barrier function Evaluation of downtime (all after 3 months) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | CO2 fractional lasers are irradiated to the inside of the left forearm at 1*1 cm (Power: 10 W, Dwell time: 600 ys, Spacing: 650 ym)
(1)a control group in which no post-treatment is performed |
|
| Interventions/Control_2 | (2)a group in which bFGF is sprayed once immediately after irradiation90 days. | |
| Interventions/Control_3 | (3)a group in which plasma is irradiated for 30 seconds. | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) According to the protocol of this study, subjects irradiated with fractional laser
2) After receiving sufficient explanation for the participation of this research, after having sufficient understanding, the examinees who obtained document agreement by the subject's free will |
|||
| Key exclusion criteria | 1) Subjects withdrew consent during and after the test
2) Subject having a history of hypersensitivity to medical plasma 3) Subjects who have either diabetes, ischemic disease, collagen disease, oral history of steroids 4) Other subjects whose examination director judged inappropriate as subjects |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | AKIO NISHIJIMA |
| Organization | Tokyo City University |
| Division name | Department of Medical Engineering, Faculty of Engineering |
| Address | 158- 8557 1-28-1 of Tamadutumi Setagaya-ku, Tokyo |
| TEL | 090-6256-5606 |
| handbal1016@yahoo.co.jp | |
| Public contact | |
| Name of contact person | AKIO NISHIJIMA |
| Organization | Tokyo City University |
| Division name | Department of Medical Engineering, Faculty of Engineering |
| Address | 158- 8557 1-28-1 of Tamadutumi Setagaya-ku, Tokyo |
| TEL | 090-6256-5606 |
| Homepage URL | |
| handbal1016@yahoo.co.jp | |
| Sponsor | |
| Institute | Tokyo City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | ClinicF |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033302 |